参考文献/References:
[1]Ichida T,Ueyama S,Eto T,et al.Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection[J].Intern Med,2019,58(2):159-166.[2]Shuichi M,Mototsugu K,Kana M,et al.Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection[J].Internal Medicine,2017,56(14):1825-1829.[3]Li WQ,Zhang JY,Ma JL,et al.Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial[J].BMJ,019,66:l5016.[4]刘少康,马燕,赵翠霞.自拟胃复汤对不同证型消化性溃疡胃泌素和血液流变学的影响[J].吉林中医药,2020,40(2):197-200.[5]Zhao M,Jiang Y,Chen Z,et al.Traditional Chinese medicine for Helicobacter pylori infection: A protocol for a systematic review and meta-analysis[J].Medicine,2021,100(3):e24282.[6]Yang Y,Wang S,Bao YR,et al.Anti-ulcer effect and potential mechanism of licoflavone by regulating inflammation mediators and amino acid metabolism[J].Journal of Ethnopharmacology,2017,199:175-182.[7]He QD,Huang MS,Zhang LB,et al.Effect of Moxibustion on Intestinal Microbiome in Acute Gastric Ulcer Rats[J].Evidence-based Complementary and Alternative Medicine,2019,2019(6):1-10.[8]邢炎华,侯少平,何志鹏.基于整合药理学的金铃子散治疗消化性溃疡的质量标志物发现及分子机制研究[J].药物评价研究,2019,42(1):56-62.[9]Hu L,Li HY,Chen WQ,et al.Ultrastructure Characteristics of Different Chinese Medicine Syndromes of Helicobacter pylori-Correlated Gastric Diseases[J].Chinese Journal of Integrative Medicine,2019,25(12):917-921.[10]王振东,崔翔,王峰,等.除幽颗粒联合三联疗法治疗脾胃虚弱证幽门螺杆菌相关胃消化性溃疡的临床研究[J].中华中医药学刊,2016,34(7):1656-1659.[11]刘强,黄鑫华,吴文斌.益胃汤合芍药甘草汤治疗胃阴亏虚型慢性胃炎患者临床效果及生活质量的影响[J].深圳中西医结合杂志,2017,27(13):84-85.[12]赵楠.温脾养胃活血通络汤配合穴位贴敷治疗脾虚血瘀证消化性溃疡效果及对胃酸分泌、创面愈合的影响[J].现代中西医结合杂志,2021,30(9):954-958.[13]刘永生.肝胃郁热型消化性溃疡应用清浊安中汤治疗的临床效果观察[J].中医临床研究,2021,13(2):58-61.[14]彭陈文,刘凤斌,王森,等.半夏泻心汤抗消化性溃疡作用机制的网络药理学研究[J].中药新药与临床药理,2019,30(12):1479-1484.[15]黄生维,王涣群,蒋福政,等.温脾养胃活血通络汤治疗消化性溃疡(脾虚血瘀证)的疗效观察[J].中国中医急症,2018,27(6):1069-1071.[16]Ling HU,Cheng M,Peiwu LI,et al.Correlation of mRNA expressions of HSP70 and IL-8 in coating on tongue,Hp infection and pathological changes of gastric mucosa in patients with different TCM patterns[J].Journal of Beijing University of Traditional Chinese Medicine,2016,39(8):653-658.[17]王晓梅.中医学“燥”的理论研究[D].哈尔滨:黑龙江中医药大学,2017.[18]曹振辉.和胃清热汤治疗肝胃郁热型胃溃疡46例临床观察[J].内蒙古中医药,2017,36(8):33.[19]武海平,武海鸥.左金丸合丹栀逍遥散对肝胃郁热型胃溃疡疗效分析[J].中国农村卫生,2017(6):13.[20]薛金洲,马燕.清浊安中汤治疗肝胃郁热型消化性溃疡疗效研究[J].陕西中医,2018,39(7):885-887.[21]王伟钦.左金丸合丹栀逍遥散治疗肝胃郁热型胃溃疡48例临床观察[J].云南中医中药杂志,2017,38(9):36-37.[22]曾霞,王振东,刘雅男,等.自制清胃止痛贴治疗肝胃郁热型消化性溃疡疗效研究[J].陕西中医,2018,39(10):1396-1398.[23]姜良铎,梁腾霄.姜良铎教授论脾胃湿热证辨治[J].中国中西医结合消化杂志,2018,26(5):389-391.[24]吴刚,郭胜红,袁华兵,等.黄芪建中汤加味方联合西药治疗消化性溃疡脾胃虚寒证疗效观察[J].现代中西医结合杂志,2018,27(11):1203-1205.[25]谢相智,许国磊,吴欣芳,等.参赭培气合吴茱萸汤治疗肝胃虚寒型反流性食管炎的临床观察[J].世界中医药,2017,12(6):1291-1293.[26]史振国,王学武.小建中汤联合西药治疗脾胃虚寒型PU的效果及对血清、胃液EGF与胃黏膜EGFR的影响研究[J].世界中西医结合杂志,2016,11(5):703-706.[27]林力森,李国政,符月敏.养胃温脾汤辅助治疗脾胃虚弱型消化性溃疡患者的疗效[J].世界中医药,2020,15(21):3323-3326.[28]王丽媛,朱伟宁,史玲.自拟疏肝和胃愈疡汤治疗肝胃不和型胃疡病的临床研究[J].中国医药导报,2021,18(23):144-147.[29]吴洁,张为民,许华冲.自拟疏肝方配合西药治疗肝胃不和型消化性溃疡的临床观察[J].世界中西医结合杂志,2018,13(10):1407-1409,1438.[30]李敏,王艳萍,李震.健胃愈疡片联合雷贝拉唑治疗肝胃不和型消化性溃疡的临床观察[J].中国药房,2016,27(9):1176-1178.[31]吴丽霞,董志霞,余利华,等.柴平汤联合加味枳术汤治疗肝胃不和型消化性溃疡对预后反酸、情志不畅及肋痛的影响[J].四川中医,2020,38(5):106-108.[32]韩广明,周军怀,赵炜,等.柴胡疏肝散对急性胃溃疡(肝胃不和型)炎症相关因子、胃黏膜表皮生长因子及受体表达的影响[J].中医药信息,2017,34(6):61-63.[33]蒋颖,蒋红心,乔明,等.三粉愈疡散联合质子泵抑制剂治疗瘀血阻络型胃溃疡的疗效观察[J].实用临床医药杂志,2021,25(18):84-86,92.[34]黄韶辉,宋金东,文时继,等.失笑散合丹参饮加味联合四联疗法治疗消化性溃疡瘀血阻络证50例[J].浙江中医杂志,2019,54(10):726-727.[35]程家军.活血愈溃汤联合雷贝拉唑治疗瘀血阻络型消化性溃疡的临床疗效[J].光明中医,2016,31(8):1150-1152.[36]叶秋丽,洪杰斐,罗磊玲.一贯煎加减治疗胃阴亏虚型慢性胃炎的疗效观察[J].黑龙江医药,2020,33(6):1317-1319.[37]马睿.益胃汤加减治疗胃阴亏虚型慢性萎缩性胃炎机理探析[J].中医临床研究,2018,10(34):82-84.[38]方得祚,张晓丽.自拟滋胃汤治疗胃阴亏虚型胃溃疡临床观察[J].光明中医,2018,33(10):1406-1407.[39]邹春阳.自拟养胃柔肝汤治疗胃阴亏虚型胃溃疡临床观察[J].四川中医,2016,33(6):97-100.
相似文献/References:
[1]郭绍敏.克拉霉素四联方案对一线方案根除失败的幽门螺杆菌的再根除效果评估[J].医学信息,2018,31(02):121.[doi:10.3969/j.issn.1006-1959.2018.02.044]
GUO Shao-min.Evaluation of the Re-eradication Effect of Clarithromycin Quadruple Regimen on Helicobacter Pylori Eradication Failure in the First Line Scheme[J].Journal of Medical Information,2018,31(20):121.[doi:10.3969/j.issn.1006-1959.2018.02.044]
[2]罗宜辉,刘代华.益生菌联合四联方案根除幽门螺杆菌的临床研究[J].医学信息,2018,31(11):25.[doi:10.3969/j.issn.1006-1959.2018.11.008]
LUO Yi-hui,LIU Dai-hua.Clinical Study on the Eradication of Helicobacter Pylori by Probiotics Combined with Quadruple Regimen[J].Journal of Medical Information,2018,31(20):25.[doi:10.3969/j.issn.1006-1959.2018.11.008]
[3]潮子健,汪文生,谢宏伟.年龄对胃部常见良性疾病患者的胃蛋白酶原及胃泌素-17水平的影响[J].医学信息,2018,31(23):105.[doi:10.3969/j.issn.1006-1959.2018.23.028]
CHAO Zi-jian,WANG Wen-sheng,XIE Hong-wei.Effect of Age on Pepsinogen and Gastrin-17 Levels in Patients with Common Benign Diseases of the Stomach[J].Journal of Medical Information,2018,31(20):105.[doi:10.3969/j.issn.1006-1959.2018.23.028]
[4]朱爱娥,王菊艳.系统护理干预对慢性胃炎及胃溃疡患者临床疗效及生活质量的影响研究[J].医学信息,2019,32(04):188.[doi:10.3969/j.issn.1006-1959.2019.04.063]
ZHU Ai-e,WANG Ju-yan.Effect of Systematic Nursing Intervention on Clinical Efficacy and Quality of Life in Patients with Chronic Gastritis and Stomach Ulcer[J].Journal of Medical Information,2019,32(20):188.[doi:10.3969/j.issn.1006-1959.2019.04.063]
[5]华启洋,吴同利,刘永艳,等.幽门螺杆菌在胃食管反流病发病中的作用[J].医学信息,2019,32(20):103.[doi:10.3969/j.issn.1006-1959.2019.20.029]
HUA Qi-yang,WU Tong-li,LIU Yong-yan,et al.The Role of Helicobacter Pylori in the Pathogenesis of Gastroesophageal Reflux Disease[J].Journal of Medical Information,2019,32(20):103.[doi:10.3969/j.issn.1006-1959.2019.20.029]
[6]王晓琼,曾凡玲.体检者胃溃疡检出率及其影响因素分析[J].医学信息,2019,32(23):132.[doi:10.3969/j.issn.1006-1959.2019.23.039]
WANG Xiao-qiong,ZENG Fan-ling.Analysis of the Detection Rate of Gastric Ulcer and its Influencing Factors in Physical Examination Patients[J].Journal of Medical Information,2019,32(20):132.[doi:10.3969/j.issn.1006-1959.2019.23.039]
[7]陶源,徐俊林,张艳,等.上消化道黏膜病变病理诊断结果分析[J].医学信息,2020,33(02):125.[doi:10.3969/j.issn.1006-1959.2020.02.036]
TAO Yuan,XU Jun-lin,ZHANG Yan,et al.Analysis of Pathological Diagnosis for Upper Gastrointestinal Mucosal Lesions[J].Journal of Medical Information,2020,33(20):125.[doi:10.3969/j.issn.1006-1959.2020.02.036]
[8]张运林.铝碳酸镁片联合雷贝拉唑Hp感染合并活动性消化性溃疡的安全性[J].医学信息,2020,33(24):125.[doi:10.3969/j.issn.1006-1959.2020.24.035]
ZHANG Yun-lin.The Safety of Hydrotalcite Tablets Combined with Rabeprazole Hp Infection with Active Peptic Ulcer[J].Journal of Medical Information,2020,33(20):125.[doi:10.3969/j.issn.1006-1959.2020.24.035]
[9]刘敏芝,李运泽.幽门螺杆菌的治疗现状[J].医学信息,2021,34(15):35.[doi:10.3969/j.issn.1006-1959.2021.15.010]
LIU Min-zhi,LI Yun-ze.Current Status of Treatment of Helicobacter Pylori[J].Journal of Medical Information,2021,34(20):35.[doi:10.3969/j.issn.1006-1959.2021.15.010]
[10]周 政.胃息肉与幽门螺杆菌感染的关系[J].医学信息,2021,34(21):91.[doi:10.3969/j.issn.1006-1959.2021.21.023]
ZHOU Zheng.Relationship Between Gastric Polyps and Helicobacter Pylori Infection[J].Journal of Medical Information,2021,34(20):91.[doi:10.3969/j.issn.1006-1959.2021.21.023]
[11]黄 飞.不同用药方案治疗幽门螺杆菌感染胃溃疡的效果比较[J].医学信息,2020,33(16):156.[doi:10.3969/j.issn.1006-1959.2020.16.050]
HUANG Fei.Comparison of the Effects of Different Medication Regimens in the Treatment of Gastric Ulcer Infected by Helicobacter Pylori[J].Journal of Medical Information,2020,33(20):156.[doi:10.3969/j.issn.1006-1959.2020.16.050]
[12]王蓓蓓,白 梅.黄芪建中汤加减联合四联疗法对Hp阳性胃溃疡患者Hp清除率及复发率的影响[J].医学信息,2022,35(20):145.[doi:10.3969/j.issn.1006-1959.2022.20.040]
WANG Bei-bei,BAI Mei.Effect of Huangqi Jianzhong Decoction Combined with Quadruple Therapy on Hp Clearance Rate and Recurrence Rate in Patients with Hp Positive Gastric Ulcer[J].Journal of Medical Information,2022,35(20):145.[doi:10.3969/j.issn.1006-1959.2022.20.040]
[13]郭秋明,黄二苟.替普瑞酮联合改良四联疗法治疗Hp阳性胃溃疡的效果及对患者心理状态的影响[J].医学信息,2023,36(20):153.[doi:10.3969/j.issn.1006-1959.2023.20.031]
GUO Qiu-ming,HUANG Er-gou.Effect of Teprenone Combined with Modified Quadruple Therapy on Hp Positive Gastric Ulcer and its Effect on Psychological State[J].Journal of Medical Information,2023,36(20):153.[doi:10.3969/j.issn.1006-1959.2023.20.031]